Showing results (1-10 of 796) with videos related to
Sort By:
Pageof 80
Cell|September 26, 2024
Mechanisms of long COVID and the path toward therapeuticsMichael J Peluso, Steven G DeeksTrends in Immunology|March 11, 2022
Early clues regarding the pathogenesis of long-COVIDMichael J Peluso, Steven G DeeksScience Translational Medicine|June 17, 2011
Breaking free of sample size dogma to perform innovative translational researchPeter Bacchetti, Steven G Deeks, Joseph M McCuneNature|December 20, 2019
Why and where an HIV cure is needed and how it might be achievedThumbi Ndung'u, Joseph M McCune, Steven G DeeksCurrent Opinion in Immunology|June 5, 2012
Immunosenescence and HIVSteven G Deeks, Eric Verdin, Joseph M McCuneScience Translational Medicine|November 13, 2024
Infection-associated chronic conditions: Why Long Covid is our best chance to untangle Osler's webMichael J Peluso, Maureen R Hanson, Steven G DeeksCell Stem Cell|February 7, 2012
Hematopoietic-stem-cell-based gene therapy for HIV diseaseHans-Peter Kiem, Keith R Jerome, Steven G Deeks, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2008
HIV-induced changes in T cell signaling pathwaysMarc Schweneker, David Favre, Jeffrey N Martin, et al.AIDS Research and Therapy|September 3, 2014
Levels of circulating myeloid subpopulations and of heme oxygenase-1 do not predict CD4(+) T cell recovery after the initiation of antiretroviral therapy for HIV diseaseLillian Seu, Gabriel M Ortiz, Trevor D Burt, et al.The Journal of Biological Chemistry|January 13, 2009
Suberoylanilide hydroxamic acid reactivates HIV from latently infected cellsXavier Contreras, Marc Schweneker, Ching-Shih Chen, et al.Pageof 80